Adlai Nortye ANL
NASDAQ ANL
$10.04 -1.11 (-9.96%)
As of: Nov 10, 2026 · 2:54 PM EST

Adlai Nortye (ANL) Common Equity (2022 - 2026)

Updated

Adlai Nortye's Common Equity was $214.83 million in Q2 2026, compared with $7.92 million a year earlier.

Analysis

Adlai Nortye (ANL) Common Equity (2022 - 2026) Analysis & Trends

At the end of FY2025, Common Equity at Adlai Nortye came in at -$8.32 million.

  • In earlier years, Common Equity was $25.49 million in FY2024 (-66.0%), $75.05 million in FY2023, -$241.29 million in FY2022 and -$185.43 million in FY2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Common Equity (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn 40.27 Bn
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn 81.53 Bn
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn -4.58 Bn
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn 44.95 Bn
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn 41.95 Bn
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn 50.37 Bn
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn 14.35 Bn
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn 13.04 Bn
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn 89.30 Bn
10 Adlai Nortye 342.45 Mn 139.24 Mn - -8.32 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 214.83 Mn
Dec 31, 2025 -8.32 Mn
Jun 30, 2025 7.92 Mn
Dec 31, 2024 25.49 Mn
Jun 30, 2024 98.02 Mn
Dec 31, 2023 75.05 Mn
Dec 31, 2022 -241.29 Mn
API Access

Adlai Nortye Common Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=common-equity&ticker=ANL&period=max&api_key=YOUR_API_KEY